Old Web
English
Sign In
Acemap
>
authorDetail
>
Piet P.M.M. Geusens
Piet P.M.M. Geusens
Barts Health NHS Trust
Secukinumab
Medicine
signs and symptoms
Alternative medicine
Physical therapy
3
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 3-year efficacy and safety results from phase 3 future 1 trial
2017
Philip J. Mease
Arthur Kavanaugh
Andreas M. Reimold
Hasan Tahir
Juergen Rech
Stephen Hall
Piet P.M.M. Geusens
Pellet Pascale
Evie Marie Delicha
Luminata Pricop
Shepard Mpofu
Show All
Source
Cite
Save
Citations (1)
SAT0470 Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 3-year efficacy and safety results from phase 3 future 1 trial
2017
Annals of the Rheumatic Diseases
P. Mease
A. Kavanaugh
Andreas M. Reimold
Hasan Tahir
J. Rech
Stephen Hall
Piet P.M.M. Geusens
P. Pascale
Evie Maria Delicha
Luminita Pricop
Shephard Mpofu
Show All
Source
Cite
Save
Citations (6)
Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 2-year efficacy and safety results from the phase 3 randomised, double-blind, placebo-controlled trial FUTURE 1
2016
Annals of the Rheumatic Diseases
J. Rech
M. Reinhardt
A. Kavanaugh
Piet P.M.M. Geusens
Shephard Mpofu
Show All
Source
Cite
Save
Citations (1)
1